Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-14

Clinical Trial Update: Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia [NA]

View source ↗

Summary

A double-blind trial tested a probiotic supplement for reducing symptoms in schizophrenia and schizoaffective disorder; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic supplement

Snippet

Sponsor: Sheppard Pratt Health System | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2013-11-14